|
|
|
|
Levodopa in combination with selegline seemed to confer no clinical benefit over levodopa alone in treating early,mild Parkinson's disease. Moreover,mortality was significantly higher with combination treatment, casting counts on its chronic use in Parkinson's disease. |
|